Pivotal Role of Timely Basal Insulin Replacement After Metformin Failure in Sustaining Long-Term Blood Glucose Control at a Target in Type 2 Diabetes

被引：9

作者：

Bolli, Geremia B. ^{[1
]}

Porcellati, Francesca ^{[1
]}

Lucidi, Paola ^{[1
]}

Fanelli, Carmine G. ^{[1
]}

机构：

[1] Univ Perugia, Dept Internal Med, Sect Internal Med Endocrinol & Metab, I-06100 Perugia, Italy

来源：

DIABETES CARE | 2011年 / 34卷

关键词：

BETA-CELL FUNCTION; NPH INSULIN; GLYCEMIC CONTROL; PEPTIDE-1; ANALOG; LOWERING DRUGS; NAIVE PEOPLE; LIVER FAT; ADD-ON; GLARGINE; THERAPY;

D O I：

10.2337/dc11-s224

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

[No abstract available]

引用

页码：S220 / S224

页数：5

共 45 条

[21]

LUCIDI P, DIABETES CA IN PRESS

[22] Comparison of the pharmacokinetics and pharmacodynamics of biphasic insulin aspart and insulin glargine in people with type 2 diabetest [J].

Luzio, S ;

Dunseath, G ;

Peter, R ;

Pauvaday, V ;

Owens, DR .

DIABETOLOGIA, 2006, 49 (06) :1163-1168

[23] Sulfonylurea induced β-cell apoptosis in cultured human islets [J].

Maedler, K ;

Carr, RD ;

Bosco, D ;

Zuellig, RA ;

Berney, T ;

Donath, MY .

JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2005, 90 (01) :501-506

[24] Fatty acids, lipotoxicity and insulin secretion [J].

McGarry, JD ;

Dobbins, RL .

DIABETOLOGIA, 1999, 42 (02) :128-138

[25] Negative binomial meta-regression analysis of combined glycosylated hemoglobin and hypoglycemia outcomes across eleven phase III and IV studies of insulin glargine compared with neutral protamine Hagedorn insulin in type 1 and type 2 diabetes mellitus [J].

Mullins, Peter ;

Sharplin, Peter ;

Yki-Jarvinen, Hannele ;

Riddle, Matthew C. ;

Haering, Hans-Ulrich .

CLINICAL THERAPEUTICS, 2007, 29 (08) :1607-1619

[26]

Nathan DM, 2008, DIABETES CARE, V31, P173, DOI [10.2337/dc08-0545, 10.2337/dc08-9016]

[27] NORMALIZATION OF FASTING HYPERGLYCEMIA BY EXOGENOUS GLUCAGON-LIKE PEPTIDE-1 (7-36 AMIDE) IN TYPE-2 (NON-INSULIN-DEPENDENT) DIABETIC-PATIENTS [J].

NAUCK, MA ;

KLEINE, N ;

ORSKOV, C ;

HOLST, JJ ;

WILLMS, B ;

CREUTZFELDT, W .

DIABETOLOGIA, 1993, 36 (08) :741-744

[28] Treatment With the Human Once-Weekly Glucagon-Like Peptide-1 Analog Taspoglutide in Combination With Metformin Improves Glycemic Control and Lowers Body Weight in Patients With Type 2 Diabetes Inadequately Controlled With Metformin Alone A double-blind placebo-controlled study [J].

Nauck, Michael A. ;

Ratner, Robert E. ;

Kapitza, Christoph ;

Berria, Rachele ;

Boldrin, Mark ;

Balena, Raffaella .

DIABETES CARE, 2009, 32 (07) :1237-1243

[29] Beyond the era of NPH insulin - Long-acting insulin analogs: Chemistry, comparative pharmacology, and clinical application [J].

Owens, D. R. ;

Biol, F. I. ;

Bolli, G. B. .

DIABETES TECHNOLOGY & THERAPEUTICS, 2008, 10 (05) :333-349

[30] Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes [J].

Patel, Anushka ;

MacMahon, Stephen ;

Chalmers, John ;

Neal, Bruce ;

Billot, Laurent ;

Woodward, Mark ;

Marre, Michel ;

Cooper, Mark ;

Glasziou, Paul ;

Grobbee, Diederick ;

Hamet, Pavel ;

Harrap, Stephen ;

Heller, Simon ;

Liu, Lisheng ;

Mancia, Giuseppe ;

Mogensen, Carl Erik ;

Pan, Changyu ;

Poulter, Neil ;

Rodgers, Anthony ;

Williams, Bryan ;

Bompoint, Severine ;

de Galan, Bastiaan E. ;

Joshi, Rohina ;

Travert, Florence .

NEW ENGLAND JOURNAL OF MEDICINE, 2008, 358 (24) :2560-2572

← 1 2 3 4 5 →